Extrapyramidal Side Effects Flashcards
Full complement of extrapyramidal side effects from antidopaminergics
- Acute dystonias
- Neuroleptic parkinsonism
- Akithisia
- Neuroleptic malignant syndrome
- Tardive dyskinesia / Tardive disorders
Risk factors for medication-induced acute dystonic reaction
- Male biological sex
- Young age
- High dose of antipsychotic
- 1st generation antipsychotic
Neuroleptic-induced parkinsonism
“Pill-rolling” resting tremor, cogwheel rigidity, bradykinesia/akinesia
Generally occurs within a few weeks of the initiation or increase in dose of an antipsychotic
Risk factors for medication-induced parkinsonism
- Older age
- Male biological sex
Single most common dopamine-antagonist induced movement disorder
Akathisia
Akathisia
Described as a subjective feeling of restlessness, which may include anxiety, pacing, or frequent sitting/standing
Generally occurs within several days to weeks of starting or increasing the dose of a dopamine antagonist
Risk factors for medication-induced akathisia
- Older age
- Female biological sex
NMS timecourse and treatment
Develops within 30 days of initiation/dose increase of antipsychotics
Which dystonic reactions require emergent treatment?
Occulogyric crisis
Laryngospasm
Some common/classical dystonic reactions
Occulogyric crisis
Torticollis
Retrocollis
Laryngospasm
Treatment of an acute dystonic reaction
Anticholinergics (namely benztropine) OR centrally acting antihistamines with anticholinergic activity (namely diphenylhydramine)
Resolutuon is rapid following administration of these medications, but doses may need to be repeated one or several times.
Once the acute episode is addressed, consideration should be given to decreasing antipsychotic dose, switching to an antipsychotic less likely to cause dystonia, or continuing oral anticholinergic agents.
Treating medication-induced akathisia
Beta blockers, if treatment is necessary
However, if the patient is just starting out on antipsychotic therapy, the preferred method is to switch to a different antipsychotic or try a lower dose
Treatment of tardive dyskinesia
Remove the offending agent
Clonazepam or valbenazine (selective vesicular monoamine transporter-2 inhibitor) are FDA approved for this condition
Treatment of drug-induced parkinsonism
Treated with anticholinergic agents, such as benztropine or diphenylhydramine
Similar thought process to acute dystonias, but more chronically.